Shay Capital LLC

Position in TMO — Thermo Fisher Scientific Inc.

CIK 1723643 NEW YORK, NY

Back to TMO Full portfolio

Position in TMO

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$10,744,144

-$5,198,631 QoQ

Shares Held

21,430

-33.9% QoQ

Ownership

0.006%

of shares outstanding

% of Portfolio

1.23%

of 13F equity value

Holder Rank

#632

of 2,620 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in TMO Over Time

Shares Held

Position Value (USD)

Derivatives in TMO

reported options exposure · as of Mar 31, 2026

CallValue

$2,703,415

CallShares

5,500

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

Shay Capital LLC holds $13,410,581 across 3 Diagnostics & Research names. TMO ranks #1 (80.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TMO	Thermo Fisher Scientific Inc. This page	21,430	$10,744,144
2	FRNM	Freenome, Inc.	213,912	$2,327,362
3	QGEN	Qiagen N.V.	8,672	$339,075

All Filings in TMO

Export CSV

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$10,744,144	21,430	-33.9%	Shares	Sole	2026-08-14
2026-03-31	$2,703,415	5,500	—	Call	Sole	2026-05-15
2026-03-31	$15,942,775	32,435	+6387.0%	Shares	Sole	2026-05-15
2025-12-31	$289,725	500	—	Shares	Sole	2026-02-17
No filing history on record for this holder in this stock.